ACM
MRK icon

Anfield Capital Management’s Merck MRK Stock Holding History

Anfield Capital Management’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$161K Buy
1,338
+1,020
+321% +$118K 0.04% 146
2025
Q4 		$33.5K Buy
318
+13
+4% +$1.22K 0.01% 220
2025
Q3 		$25.6K Sell
305
-16
-5% -$1.32K 0.01% 238
2025
Q2 		$25.4K Buy
321
+35
+12% +$2.78K 0.01% 217
2025
Q1 		$25.7K Hold
286
– – 0.01% 181
2024
Q4 		$28.5K Sell
286
-15
-5% -$1.55K 0.01% 167
2024
Q3 		$34.2K Buy
301
+125
+71% +$14.9K 0.01% 152
2024
Q2 		$21.8K Buy
+176
New +$22.7K 0.01% 143
2023
Q1 		– Sell
-1,605
Closed -$178K – 84
2022
Q4 		$178K Sell
1,605
-2,310
-59% -$236K 0.09% 65
2022
Q3 		$337K Buy
3,915
+135
+4% +$12.1K 0.16% 62
2022
Q2 		$345K Buy
3,780
+540
+17% +$47.9K 0.16% 61
2022
Q1 		$266K Buy
+3,240
New +$255K 0.1% 69
2021
Q3 		– Sell
-183
Closed -$14K – 208
2021
Q2 		$14K Buy
+183
New +$13.6K 0.01% 153
2020
Q3 		– Sell
-7,728
Closed -$592K – 91
2020
Q2 		$592K Buy
7,728
+137
+2% +$10.3K 0.23% 55
2020
Q1 		$557K Sell
7,591
-23
-0.3% -$1.81K 0.32% 57
2019
Q4 		$624K Buy
+7,614
New +$625K 0.25% 63

Other funds holding MRK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Anfield Capital Management's MRK Position: Q1 2026 in Review

Anfield Capital Management increased its Merck (MRK) stake by 321% in Q1 2026, buying an estimated $118K and bringing the position to 1,338 shares worth $161K. The position accounts for 0.04% of the portfolio, ranked #146.

Anfield Capital Management first reported a position in MRK in Q4 2019 and has held it in 16 quarters since. The position peaked at $624K in Q4 2019. 3,779 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Anfield Capital Management held 1,338 shares of Merck worth $161K as of Q1 2026.
  • Anfield Capital Management bought 1,020 Merck shares in Q1 2026, an estimated $118K.
  • Merck made up 0.04% of Anfield Capital Management's portfolio in Q1 2026, its #146 holding.
  • Anfield Capital Management first reported a position in Merck in Q4 2019 and has held it in 16 quarters since.
  • Anfield Capital Management's Merck position peaked at $624K in Q4 2019.
  • 3,779 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Anfield Capital Management's 13F filing for Q1 2026, filed 12 May 2026.